6 results
425
EX-99.1
AEON
AEON Biopharma Inc. - Ordinary Shares
30 Jun 23
Business combination disclosure
8:29am
that the proposed transaction disrupts current plans of AEON and potential difficulties in AEON employee retention as a result of the proposed transaction, (viii
DEFA14A
EX-99.1
AEON
AEON Biopharma Inc. - Ordinary Shares
30 Jun 23
Additional proxy soliciting materials
8:27am
that the proposed transaction disrupts current plans of AEON and potential difficulties in AEON employee retention as a result of the proposed transaction, (viii
8-K
EX-99.1
AEON
AEON Biopharma Inc. - Ordinary Shares
30 Jun 23
AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination
8:26am
that the proposed transaction disrupts current plans of AEON and potential difficulties in AEON employee retention as a result of the proposed transaction, (viii
425
EX-99.1
AEON
AEON Biopharma Inc. - Ordinary Shares
27 Dec 22
Business combination disclosure
5:30pm
employee retention as a result of the proposed transaction, (viii) the outcome of any legal proceedings that may be instituted against AEON or against
8-K
EX-99.1
AEON
AEON Biopharma Inc. - Ordinary Shares
27 Dec 22
AEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business Combination
5:04pm
employee retention as a result of the proposed transaction, (viii) the outcome of any legal proceedings that may be instituted against AEON or against
425
cmc34zdd
21 Dec 22
Business combination disclosure
3:02pm
- Prev
- 1
- Next